Plain-English translation of NCT04841447 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how DPP4 inhibitors might help treat certain blood cancers, particularly acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). By collecting blood and bone marrow samples from patients, the team wants to understand how this medication affects leukemia stem cells—the cells that can cause the disease to return. The goal is to develop personalized treatments that could keep leukemia from coming back once a patient is in remission.
Current leukemia treatments don't always prevent the disease from returning because they may not fully eliminate the leukemia stem cells responsible for regrowth. Researchers believe this medication might target these stubborn cells in a new way, and they need patient samples to test this idea and learn whether adding this treatment during remission could improve long-term outcomes.
You likely qualify if…
You likely don't qualify if…
You would provide blood and bone marrow samples that researchers will study in the laboratory and potentially use to test how the medication affects your leukemia cells. The study does not involve taking the medication yourself—it is purely a research sample collection to help scientists understand whether this approach might work for future patients. Your specific visits and timeline would be discussed with the research team at the University of Missouri-Columbia.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States